Indian Pharma industry needs to address climate change challenges

Indian Pharma industry vs Climate change challenges

124
Medicines
Picture: Pixabay

Last Updated on November 2, 2021 by The Health Master

NEW DELHI : Indian pharma industry should gear up to address challenges arising out of climate change, biodiversity and environmental impacts, said Professor K Vijay Raghavan, Principal Scientific Adviser to the Government of India.

Speaking at the webinar on Affordability and Innovation: Ensuring Quality Drugs for All“, organised by the National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals, Professor Raghavan also dwelled on the necessity of strong industry-academia linkages and combinatorial approach of computational and experimental work to push for new drug discovery.

The webinar was organised as part of activities to commemorate the occasion of the 75th anniversary of Indian independence during the year-long ‘Azadi Ka Amrit Mahotsav‘ and was chaired by Professor Raghavan.

As per a release issued by the Ministry of Chemical and Fertiliser, S Aparna, Secretary, Department of Pharmaceuticals, while speaking on the occasion, highlighted the fact that NPPA has been at the forefront of the commitment of the government to ensure affordable medicines to patients.

She also mentioned about government’s support to industry through the PLI scheme to innovate the capacities in biologics, gene cell therapy, complex generics, and medicines of the future.

Kamlesh Kumar Pant, chairman, NPPA, during his address highlighted the role played by NPPA in making medicines available at affordable prices. He also mentioned higher prices being approved by NPPA for proposals with incremental innovations.

Novel Drug identified for the treatment for Covid-19

USFDA clears Pfizer’s C-19 Vaccine for children aged 5 to 11

Drug recall: Cook Medical recalled these Medical Devices

Needle-free Vaccine Patches coming soon, easy to apply

Govt issued notification for Form 29: License to Mfg drugs for…

DCGI nod for device-aided therapy for Parkinson’s patients

NFI 2021: Salient features of 6th Edition of National Formulary of India

Govt releases draft policy for R&D, Pharma and Medical Devices

Procedure to obtain license for manufacturing of Homoeopathic Medicines

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news